| Name | garvagliptin |
|---|---|
| Synonyms |
2H-Pyran-3-amine, 2-(2,5-difluorophenyl)tetrahydro-5-[3,4,5,6-tetrahydro-5-(methylsulfonyl)pyrrolo[3,4-c]pyrrol-2(1H)-yl]-, (2R,3S,5R)-
V6PF66H6HL garvagliptin (2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[5-(methylsulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl]tetrahydro-2H-pyran-3-amine |
| Description | A potent, selective dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment for type 2 diabetes. |
|---|---|
| References | References View Related Products by Target Dipeptidyl Peptidase (DPP) |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 528.5±60.0 °C at 760 mmHg |
| Molecular Formula | C18H23F2N3O3S |
| Molecular Weight | 399.455 |
| Flash Point | 273.4±32.9 °C |
| Exact Mass | 399.142822 |
| LogP | 1.39 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.626 |